“The FDA rocked the hearing health world on Dec. 7, 2016, by announcing its intent to consider a class of over-the-counter (OTC) hearing aids. Industry insiders buzzed that independent audiologists would suffer from falling hearing aid prices. Yet, as a patient, hearing health advocate, and an expert in patient engagement, I champion a more nuanced viewpoint: While audiologists will need to cope with falling prices, they will have the opportunity to build a new business model based on outstanding patient access, coaching, and care.”
The Hearing Journal, February 2017 – Volume 70 – Issue 2